Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Reeder

Showing results (201-210 of 223) with videos related to

Pageof 23
Sort By:
Breast Cancer Research and Treatment|February 21, 2026
Investigating initial patterns of progression on first-line treatment in patients with de novo metastatic breast cancerEmily Huber, Gaorav P Gupta, Ryan Morse, et al.
Urology|February 17, 2012
Near infrared fluorescence imaging after intravenous indocyanine green: initial clinical experience with open partial nephrectomy for renal cortical tumorsScott Tobis, Joy K Knopf, Christopher R Silvers, et al.
Breast Cancer Research and Treatment|November 11, 2017
Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancerK A Nyrop, A M Deal, S K Choi, et al.
Breast Cancer Research and Treatment|October 12, 2018
Correction to: Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancerK A Nyrop, A M Deal, S K Choi, et al.
JCO Precision Oncology|July 16, 2024
Differences in 21-Gene and PAM50 Recurrence Scores in Younger and Black Women With Breast CancerSarah C Van Alsten, Sanah N Vohra, Joannie M Ivory, et al.
Cancer Medicine|January 27, 2026
Treatment Initiation Among Black and White Older Adults With Multiple Myeloma: A SEER-Medicare AnalysisMatthew R LeBlanc, Xi Zhou, Christopher D Baggett, et al.
NPJ Breast Cancer|September 8, 2022
A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancerNatalia Mitin, Kirsten A Nyrop, Susan L Strum, et al.
Clinical Breast Cancer|September 24, 2024
Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation TherapyRyan T Morse, Nathan W Bean, Jacob Hall, et al.
JNCI Cancer Spectrum|January 14, 2021
Outcomes of Hormone-Receptor Positive, HER2-Negative Breast Cancers by Race and Tumor Biological FeaturesHalei C Benefield, Katherine E Reeder-Hayes, Hazel B Nichols, et al.
Clinical Breast Cancer|January 31, 2025
Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical TrialsDario Trapani, Qingchun Jin, Kathy D Miller, et al.
Pageof 23

Showing results (201-210 of 223) with videos related to

Sort By:
Pageof 23
Breast Cancer Research and Treatment|February 21, 2026
Investigating initial patterns of progression on first-line treatment in patients with de novo metastatic breast cancerEmily Huber, Gaorav P Gupta, Ryan Morse, et al.
Urology|February 17, 2012
Near infrared fluorescence imaging after intravenous indocyanine green: initial clinical experience with open partial nephrectomy for renal cortical tumorsScott Tobis, Joy K Knopf, Christopher R Silvers, et al.
Breast Cancer Research and Treatment|November 11, 2017
Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancerK A Nyrop, A M Deal, S K Choi, et al.
Breast Cancer Research and Treatment|October 12, 2018
Correction to: Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancerK A Nyrop, A M Deal, S K Choi, et al.
JCO Precision Oncology|July 16, 2024
Differences in 21-Gene and PAM50 Recurrence Scores in Younger and Black Women With Breast CancerSarah C Van Alsten, Sanah N Vohra, Joannie M Ivory, et al.
Cancer Medicine|January 27, 2026
Treatment Initiation Among Black and White Older Adults With Multiple Myeloma: A SEER-Medicare AnalysisMatthew R LeBlanc, Xi Zhou, Christopher D Baggett, et al.
NPJ Breast Cancer|September 8, 2022
A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancerNatalia Mitin, Kirsten A Nyrop, Susan L Strum, et al.
Clinical Breast Cancer|September 24, 2024
Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation TherapyRyan T Morse, Nathan W Bean, Jacob Hall, et al.
JNCI Cancer Spectrum|January 14, 2021
Outcomes of Hormone-Receptor Positive, HER2-Negative Breast Cancers by Race and Tumor Biological FeaturesHalei C Benefield, Katherine E Reeder-Hayes, Hazel B Nichols, et al.
Clinical Breast Cancer|January 31, 2025
Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical TrialsDario Trapani, Qingchun Jin, Kathy D Miller, et al.
Pageof 23